Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-07

Clinical Trial Update: Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intravenous ferumoxytol to oral ferrous sulfate for treating iron deficiency anemia in pregnancy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FERUMOXYTOL (ferumoxytol)
  • Ferrous sulfate (ferrous sulfate)

Snippet

Sponsor: University of Arizona | Conditions: Iron Deficiency Anemia of Pregnancy | Phase 3 | Status: COMPLETED